U.S. markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real Time Price. Currency in USD
184.04+0.94 (+0.51%)
At close: 04:00PM EST
184.38 +0.34 (+0.18%)
After hours: 06:21PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close183.10
Bid179.04 x 800
Ask188.45 x 800
Day's Range183.18 - 185.80
52 Week Range132.24 - 243.52
Avg. Volume912,014
Market Cap27.07B
Beta (5Y Monthly)0.69
PE Ratio (TTM)30.47
EPS (TTM)6.04
Earnings DateApr 25, 2024 - Apr 29, 2024
Forward Dividend & Yield1.92 (1.04%)
Ex-Dividend DateFeb 07, 2024
1y Target Est201.28
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ResMed Inc.
    RMD: Raising target price to $190.00RESMED INC has an Investment Rating of HOLD; a target price of $190.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more